Eloxx Pharmaceuticals, Inc. (ELOX)
15.51
-0.20
(-1.27%)
USD |
OTCM |
Oct 02, 16:00
15.32
-0.19
(-1.23%)
After-Hours: 20:00
Eloxx Pharmaceuticals Net Income (Quarterly) : -4.502M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -4.502M |
| March 31, 2026 | -3.754M |
| June 30, 2025 | -1.891M |
| September 30, 2023 | -3.592M |
| June 30, 2023 | -4.341M |
| March 31, 2023 | -6.23M |
| December 31, 2022 | -6.319M |
| September 30, 2022 | -7.508M |
| June 30, 2022 | -10.62M |
| March 31, 2022 | -11.62M |
| December 31, 2021 | -12.09M |
| September 30, 2021 | -9.885M |
| June 30, 2021 | -36.06M |
| March 31, 2021 | -8.694M |
| December 31, 2020 | -6.127M |
| September 30, 2020 | -6.617M |
| June 30, 2020 | -7.887M |
| March 31, 2020 | -13.95M |
| December 31, 2019 | -11.63M |
| September 30, 2019 | -12.88M |
| June 30, 2019 | -14.45M |
| March 31, 2019 | -11.92M |
| December 31, 2018 | -14.03M |
| September 30, 2018 | -11.16M |
| June 30, 2018 | -13.41M |
| Date | Value |
|---|---|
| March 31, 2018 | -8.591M |
| June 30, 2017 | -2.007M |
| March 31, 2017 | -2.066M |
| December 31, 2016 | -0.7898M |
| September 30, 2016 | -0.9336M |
| June 30, 2016 | -1.153M |
| March 31, 2016 | -3.079M |
| December 31, 2015 | -3.855M |
| September 30, 2015 | -0.1807M |
| June 30, 2015 | -0.9068M |
| March 31, 2015 | -1.227M |
| December 31, 2014 | -10.75M |
| September 30, 2014 | -5.184M |
| June 30, 2014 | -3.674M |
| March 31, 2014 | -2.147M |
| December 31, 2013 | -1.620M |
| September 30, 2013 | -1.784M |
| June 30, 2013 | -1.931M |
| March 31, 2013 | -0.8366M |
| December 31, 2012 | -1.270M |
| September 30, 2012 | -2.086M |
| June 30, 2012 | -1.439M |
| March 31, 2012 | -1.061M |
| December 31, 2011 | -1.528M |
| September 30, 2011 | -1.039M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Filana Therapeutics, Inc. | -8.603M |
| CorMedix, Inc. | 25.99M |
| BioStem Technologies, Inc. | -8.971M |
| Wave Life Sciences, Inc. | -69.36M |
| Axsome Therapeutics, Inc. | -51.31M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 4.502M |
| EPS Diluted (Quarterly) | -0.6631 |
| Enterprise Value | 0.6386M |
| Earnings Yield | -53.36% |
| Normalized Earnings Yield | -53.79 |